High materiality7/10
National Health Investors price target lowered to $80 from $90 at BMO Capital
Why it may matterVerify against the original reporting
Sell
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BMO lowers NHI target to $80; price $71.56; downgrade despite target above price.
- Target $80
- Price $71.56
- Downgrade
Key facts
- 01
Target: $80
- 02
Posted price: $71.56
- 03
Analyst firm: BMO Capital
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.